E3J-33301-75469
2 vaccinations
9 coded responses
21 check-ins
9 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 838 / ID
- Registered
- 2021-03-30
- Relationship
- Self
- Race
- N/A
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-30
Registered in v-safe
-
2021-03-30
Dose 1 — Pfizer-BioNTech
-
2021-03-30
Survey response — day 0, dose 1MedDRA: Injection site reaction, Myalgia, Paraesthesia, Peripheral coldness — Feeling: Fair · Site: Pain, Redness, Swelling · Chills, Muscle or body achesFree text: coldness and tingling down the immunized arm for about an hour after the shot, in addition to the muscle pain and injection site symptomsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-03-31
Health check-in — days 1–6 daily, dose 1Feeling: Good · Site: Pain, Redness, Swelling · NoneAdult check-in
-
2021-04-01
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention — Feeling: Fair · Site: Pain, Swelling · Fatigue or tiredness · Be unable to workFree text: trouble concentratingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Site: Pain · Headache, Abdominal painAdult check-in
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention — Feeling: Fair · Site: Pain, Swelling · Fatigue or tirednessFree text: trouble concentratingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-04
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention — Feeling: Fair · Joint pains, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: trouble concentratingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-05
Survey response — days 1–6 daily, dose 1MedDRA: Disturbance in attention — Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesFree text: trouble concentratingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-06
Health check-in — day 7, dose 1Feeling: Good · Joint pains, Muscle or body aches · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-20
Dose 2 — Pfizer-BioNTech
- 2021-04-20
-
2021-04-21
Survey response — days 1–6 daily, dose 2MedDRA: Abdominal distension, Flatulence — Feeling: Poor · Site: Pain, Redness, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Abdominal pain · Be unable to work, Be unable to do your normal daily activitiesFree text: gas/bloatingMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-22
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain, Swelling · Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-23
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-25
Health check-in — days 1–6 daily, dose 2Feeling: Poor · Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activitiesAdult check-in
-
2021-04-27
Health check-in — day 7, dose 2Feeling: Fair · Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2021-05-06
Survey response — day 14, dose 2MedDRA: Fatigue, Feeling abnormal, Pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Achiness, severe fatigue and brain fogMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-13
-
2021-05-18
Survey response — day 28, dose 2MedDRA: Fatigue, Office visit — Feeling: Fair · Be unable to work, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professionalFree text: Symptoms: Worsening fatigue · Healthcare visit (other): consultation on symptoms @ annual well visitMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-05-18
Report sent to call center — day 28, dose 2Be unable to work · Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional1 call case(s)
- 2021-05-26
- 2021-06-03
-
2021-10-19
Survey response — 6 months, dose 2MedDRA: Cardiovascular disorder, Dizziness, Fatigue, Hypertension, Somnolence, Temperature regulation disorder — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesFree text: Diagnosed with high blood pressure. Poor circulation worsened once bp controlled w/medication. Fatigue, sleepiness, dizziness; one episode of all three along with trouble regulating body temperature.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-11
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-30 | Pfizer-BioNTech | |
| 2 | 2021-04-20 | Pfizer-BioNTech |
Call center
1 call center case
1 unsuccessful
1 wait over 3 months for a first call
Free text
Release 6 — day 0, dose 1
Systemic reaction (other): coldness and tingling down the immunized arm for about an hour after the shot, in addition to the muscle pain and injection site symptoms
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): trouble concentrating
Systemic reaction (other): trouble concentrating
Systemic reaction (other): trouble concentrating
Systemic reaction (other): trouble concentrating
Release 7 — days 1–6 daily, dose 2
Systemic reaction (other): gas/bloating
Release 8 — day 14, dose 2
Symptoms: Achiness, severe fatigue and brain fog
Release 8 — day 28, dose 2
Symptoms: Worsening fatigue
Healthcare visit (other): consultation on symptoms @ annual well visit
Release 10 — 6 months, dose 2
Symptoms: Diagnosed with high blood pressure. Poor circulation worsened once bp controlled w/medication. Fatigue, sleepiness, dizziness; one episode of all three along with trouble regulating body temperature.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | ✓ | ✓ | ✓ |
| SD | Cardiovascular disorder | · | · | ✓ |
| SD | Dizziness | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Feeling abnormal | ✓ | ✓ | ✓ |
| SD | Hypertension | · | · | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Somnolence | · | · | ✓ |
| SD | Temperature regulation disorder | · | · | ✓ |
| SRO | Abdominal distension | ✓ | ✓ | ✓ |
| SRO | Disturbance in attention | ✓ | ✓ | ✓ |
| SRO | Flatulence | ✓ | ✓ | ✓ |
| SRO | Injection site reaction | ✓ | ✓ | ✓ |
| SRO | Myalgia | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
| SRO | Peripheral coldness | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release